These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 98783)

  • 1. Behavioural effects of methylphenidate in 6-hydroxydopamine-treated neonatal rats.
    Eastgate SM; Wright JJ; Werry JS
    Psychopharmacology (Berl); 1978 Jul; 58(2):157-9. PubMed ID: 98783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
    Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T
    Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate in 6-hydroxydopamine-treated developing rat pups. Effects on activity and maze performance.
    Shaywitz BA; Klopper JH; Gordon JW
    Arch Neurol; 1978 Jul; 35(7):463-9. PubMed ID: 566540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects of neonatal systemic 6-hydroxydopamine.
    Saari M; Pappas BA
    Neuropharmacology; 1978 Oct; 17(10):863-71. PubMed ID: 745682
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN; McLean JH; Kostrzewa RM
    Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of 6-hydroxydopamine.
    De Carolis AS; Ziegler H; Del Basso P; Longo VG
    Physiol Behav; 1971 Nov; 7(5):705-8. PubMed ID: 5170825
    [No Abstract]   [Full Text] [Related]  

  • 8. The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.
    Vetulani J; Reichenberg K; Wiszniowska G
    Psychopharmacologia; 1974; 38(2):173-80. PubMed ID: 4460073
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Place preference conditioning with methylphenidate and nomifensine.
    Martin-Iverson MT; Ortmann R; Fibiger HC
    Brain Res; 1985 Apr; 332(1):59-67. PubMed ID: 3922561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early behavioral and catecholaminergic effects of 6-hydroxydopamine and guanethidine in the neonatal rat.
    Pappas BA; Peters DA; Sobrian AK; Blouin A; Drew B
    Pharmacol Biochem Behav; 1975; 3(4):681-5. PubMed ID: 242015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
    Pappas BA; Sobrian SK
    Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
    [No Abstract]   [Full Text] [Related]  

  • 15. Environmental influences on body weight and behavior in developing rats after neonatal 6-hydroxydopamine.
    Pearson DE; Teicher MH; Shaywitz BA; Cohen DJ; Young JG; Anderson GM
    Science; 1980 Aug; 209(4457):715-7. PubMed ID: 7394533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 6-hydroxydopamine administration to neonatal rats on some endocrine and behavioral parameters.
    van Delft AM; Nyakas C; Kaplanski J; Tilders FJ
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):403-4. PubMed ID: 4778634
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of phenobarbital on activity and learning in 6-hydroxydopamine treated rat pups.
    Shaywitz BA; Pearson DA
    Pharmacol Biochem Behav; 1978 Aug; 9(2):173-9. PubMed ID: 714967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
    Iwasaki T; Takasuna M
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):381-8. PubMed ID: 3103348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
    Peters DA; Pappas BA; Taub H; Saari M
    Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
    Davids E; Zhang K; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.